Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

First, it's difficult for the cancer hunters to get inside a tumor. Second, not all the cancer cells necessarily have the structure the T-cells can recognize and attack. And third, solid tumors in ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...

Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself ...

Researchers at the University of Virginia have discovered a new mechanism driving drug resistance in pancreatic ductal ...